BRCA2 c.2059_2061delinsTAA ;(p.D687*)

Variant ID: 13-32910551-GAT-TAA

NM_000059.3(BRCA2):c.2059_2061delinsTAA;(p.D687*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.

Jco Global Oncology
Gupta, Sudeep S; Rajappa, Senthil S; Advani, Suresh S; Agarwal, Amit A; Aggarwal, Shyam S; Goswami, Chanchal C; Palanki, Satya Dattatreya SD; Arya, Devavrat D; Patil, Shekhar S; Kodagali, Rohit R
Publication Date: 2021-06

Variant appearance in text: BRCA2: Asp687ter
PubMed Link: 34101484
Variant Present in the following documents:
  • go-7-go.21.00051.pdf
View BVdb publication page



Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.

Plos One
LaDuca, Holly H; Farwell, Kelly D KD; Vuong, Huy H; Lu, Hsiao-Mei HM; Mu, Wenbo W; Shahmirzadi, Layla L; Tang, Sha S; Chen, Jefferey J; Bhide, Shruti S; Chao, Elizabeth C EC
Publication Date: 2017

Variant appearance in text: BRCA2: D687*
PubMed Link: 28152038
Variant Present in the following documents:
  • pone.0170843.s003.xlsx, sheet 1
View BVdb publication page